Provided by Tiger Trade Technology Pte. Ltd.

Exact Sciences

104.91
0.0000
Volume:- -
Turnover:2.26B
Market Cap:20.02B
PE:-95.19
High:104.91
Open:104.91
Low:104.91
Close:104.91
52wk High:104.98
52wk Low:38.81
Shares:190.81M
Float Shares:187.46M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1021
EPS(LYR):-1.1021
ROE:-8.66%
ROA:-1.59%
PB:8.34
PE(LYR):-95.19

Loading ...

Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), HeartFlow, Inc. (HTFL) and Pelthos Therapeutics (PTHS)

TIPRANKS
·
Feb 17

Exact Sciences Faces Rising Operational Risk and Strategic Constraints Amid Pending Abbott Merger

TIPRANKS
·
Feb 15

Soros Fund Management's Q4 Portfolio Shifts: Trims Snowflake, Boosts Microsoft and NVIDIA, Initiates Gold Position

Stock News
·
Feb 14

Cancer diagnostics firm Exact Sciences' Q4 revenue rises

Reuters
·
Feb 14

Exact Sciences Q4 Loss Narrows, Revenue Rises

MT Newswires Live
·
Feb 14

Exact Sciences reports Q4 EPS (45c) vs (27c) last year

TIPRANKS
·
Feb 14

Exact Sciences Q4 free cash flow surges nearly fivefold to USD 357 million

Reuters
·
Feb 14

BRIEF-Exact Sciences Q4 Basic EPS USD -0.45

Reuters
·
Feb 14

Exact Sciences Q4 Net Income USD -85.955 Million

THOMSON REUTERS
·
Feb 14

Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results

THOMSON REUTERS
·
Feb 14

Exact Sciences Faces Shareholder Lawsuits Over Abbott Merger

TIPRANKS
·
Feb 11

Assessing Exact Sciences (EXAS) Valuation After Oncotype DX Reaches 2 Million Patients

Simply Wall St.
·
Feb 08

Geneoscopy: Ptab's Ruling Concluded That All Claims of '746 Patent Challenged by Exact Sciences Before Ptab Are Unpatentable

THOMSON REUTERS
·
Feb 07

Geneoscopy: Ptab's Ruling Confirms Geneoscopy's Long-Held Position and Clears Path for Continued Commercialization of Colosense

THOMSON REUTERS
·
Feb 07

Exact Sciences ‘applauds’ passage of MCED legislation

TIPRANKS
·
Feb 04

BRIEF-German Cartel Office Approved Planned Acquisition Of Exact Sciences By Abbott

Reuters
·
Jan 30

German Cartel Office: Approved Planned Acquisition of Exact Sciences Corporation by Abbott Laboratories in Preliminary Proceedings

THOMSON REUTERS
·
Jan 30

Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints

Benzinga
·
Jan 22

Abbott Q4 sales misses analyst expectations, hurt by diagnostics unit's challenges

Reuters
·
Jan 22

Abbott Labs Seen Posting Higher 4Q Sales Amid Pending Buyout of Exact Sciences -- Earnings Preview

Dow Jones
·
Jan 22